According to Biotest 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.94693. At the end of 2023 the company had a P/S ratio of 2.08.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.08 | -30.48% |
2022 | 3.00 | -1.3% |
2021 | 3.04 | 23.44% |
2020 | 2.46 | 31.14% |
2019 | 1.88 | -21.31% |
2018 | 2.38 | -29.31% |
2017 | 3.37 | 212.14% |
2016 | 1.08 | -4.55% |
2015 | 1.13 | -41.78% |
2014 | 1.94 | -7.68% |
2013 | 2.11 | 55.13% |
2012 | 1.36 | 27.05% |
2011 | 1.07 | -30.05% |
2010 | 1.53 |